ArticleMedicine2026
Mapping the global research landscape and hotspots of traditional herbal medicine for inflammatory bowel disease: A bibliometric analysis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Traditional herbal medicine, which utilizes herbal materials for complementary, alternative, and integrative therapies, has seen increasing application across diverse medical fields in recent decades, including the treatment of inflammatory bowel disease (IBD). To our knowledge, no bibliometric analyses have been conducted over the past 3 decades to evaluate the global research landscape of herbal medicine applications in IBD treatment. We performed a bibliometric analysis of scientific publications indexed in the Web of Science database in the past 3 decades (1990-2023), focusing on studies related to IBD treatments involving herbal medicines, including decoctions, formulas, herbal plants, and natural derivatives. By our analysis, China emerged as the most productive country in this field, with Nanjing University of Chinese Medicine contributing the highest number of publications. Hsiao Chung-Der was identified as the most prolific author, while Markus F. Neurath ranked as the most cited author. Journals such as Frontiers in Pharmacology, Journal of Ethnopharmacology, and Evidence-Based Complementary and Alternative Medicine were not only the top publishers but also the most frequently cited sources. Our analysis further revealed that the most widely used herbal decoctions and herbal plants exhibit shared molecular targets and signaling pathways with therapeutic potential against IBD. This study provides a systematic, visualized, and objective evaluation of research trends, offering insights to guide future investigations in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.